|
(+)-(2S)-2-(4-chloro-2-methoxyphenyl)-2-{[3-methoxy-5-(methylsulfonyl)phenyl]amino}-1-[5-(trifluoromethoxy)-1H-indol-3-yl]ethanone |
|---|---|
| Trade Name | |
| Orphan Indication | Dengue virus infection |
| USA Market Approval | USA |
| USA Designation Date | 2017-12-26 00:00:00 |
| Sponsor | Janssen Research & Development, LLC;125 Trenton-Harbourton Road;Titusville, New Jersey, 08560 |
